http://www.unboundmedicine.com/medline/ebm/research/anagrelideUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19887779/full_citation/Anagrelide_Treatment_in_Early_Pregnancy_in_a_Patient_with_JAK2V617F_Positive_Essential_Thrombocythemia:_Case_Report_and_Literature_Review_Sobas MA, Pérez Encinas MM, Rabuñal Martinez MJ, et al. 
Anagrelide Treatment in Early Pregnancy in a Patient with JAK2V617F-Positive Essential Thrombocythemia: Case Report and Literature Review. [JOURNAL ARTICLE]
Acta Haematol 2009 Oct 29; 122(4):221-222.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19713696/full_citation/Wild_Type_JAK2_Secondary_Acute_Erythroleukemia_Developing_after_JAK2_V617F_Mutated_Primary_Myelofibrosis_Kreft A, Springer E, Lipka DB, et al. 
Wild-Type JAK2 Secondary Acute Erythroleukemia Developing after JAK2-V617F-Mutated Primary Myelofibrosis. [JOURNAL ARTICLE]
Acta Haematol 2009 Aug 28; 122(1):36-38.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19636672/full_citation/Essential_thrombocythemia:_past_and_present_Fabris F, Randi ML 
Essential thrombocythemia: past and present. [JOURNAL ARTICLE]
Intern Emerg Med 2009 Jul 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19501853/full_citation/[Retrospective_analysis_of_the_efficacy_and_tolerability_of_anagrelide_in_patients_with_essential_thrombocytemia:_Spanish_registry_of_essential_thrombocytemia_]Giralt M, Navas V, Hernández-Nieto L, et al. 
[Retrospective analysis of the efficacy and tolerability of anagrelide in patients with essential thrombocytemia: Spanish registry of essential thrombocytemia.] [JOURNAL ARTICLE]
Med Clin (Barc) 2009 Jun 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19395976/full_citation/Atypical_Takotsubo_syndrome_during_anagrelide_therapy_Proietti R, Rognoni A, Ardizzone F, et al. 
Atypical Takotsubo syndrome during anagrelide therapy. [JOURNAL ARTICLE]
J Cardiovasc Med (Hagerstown) 2009 Apr 23.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19364963/full_citation/Reticulin_Accumulation_in_Essential_Thrombocythemia:_Prognostic_Significance_and_Relationship_to_Therapy_Campbell PJ, Bareford D, Erber WN, et al. 
Reticulin Accumulation in Essential Thrombocythemia: Prognostic Significance and Relationship to Therapy. [JOURNAL ARTICLE]
J Clin Oncol 2009 Apr 13.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19302911/full_citation/Pharmacokinetics_bioequivalence_tolerability_and_effects_on_platelet_counts_of_two_formulations_of_anagrelide_in_healthy_volunteers_and_patients_with_thrombocythemia_associated_with_chronic_myeloproliferation_Petrides PE, Gisslinger H, Steurer M, et al. 
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2009 Feb; 31(2):386-98.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19154659/full_citation/Limited_efficacy_of_hydroxyurea_in_lowering_of_the_JAK2_V617F_allele_burden_Larsen TS, Pallisgaard N, de Stricker K, et al. 
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden. [Journal Article]
Hematology 2009 Feb; 14(1):11-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19154658/full_citation/Anagrelide_for_the_treatment_of_essential_thrombocythemia:_a_survey_among_European_hematologists/oncologists_Reilly JT 
Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists. [Journal Article]
Hematology 2009 Feb; 14(1):1-10.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19129692/full_citation/Hydroxyurea_and_anagrelide_combination_therapy_in_patients_with_chronic_myeloproliferative_diseases_resistant_or_intolerant_to_monotherapy_Christoforidou A, Pantelidou D, Anastasiadis A, et al. 
Hydroxyurea and anagrelide combination therapy in patients with chronic myeloproliferative diseases resistant or intolerant to monotherapy. [Journal Article]
Acta Haematol 2008; 120(4):195-8.
Full Citation | Publisher Full Text | Find Related Articles